Last update:

Oncology & Cancer news

Oncology & Cancer

Lowering cancer drug dose could open tumors to immunotherapy

Research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the tumor's response to immunotherapy.

Oncology & Cancer

Novel treatment regimen yields promising response in advanced-phase chronic myeloid leukemia

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML)—including both accelerated or ...

Oncology & Cancer

How AI can help researchers make esophageal cancer less deadly

Approximately 600 times a day, the esophagus ferries whatever is in your mouth down to your stomach. It's usually a one-way route, but sometimes acid escapes the stomach and travels back up. That can damage the cells lining ...

Medications

FDA expands use of breast cancer drug Kisqali

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced ...

Oncology & Cancer

Tool to study new treatments for liver cancer

A team led by Sylvain Meloche, Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signaling and Cell Growth Research Unit, has developed a new preclinical model for the study of the most common subtype of ...

Oncology & Cancer

Early, virtual palliative care feasible for advanced lung cancer

The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with advanced non-small cell lung cancer (NSCLC), according to a study published online Sept. 11 in the Journal ...

Oncology & Cancer

New tumor models provide insights into deadly sarcomas

Sarcomas are highly metastatic soft tissue and bone cancers and are often difficult to treat. Scientists have had trouble studying these cancers because they have lacked good research models. But that may be changing, thanks ...

Oncology & Cancer

10-year study shows tomosynthesis improves breast cancer detection

According to a new 10-year study, screening for breast cancer with digital breast tomosynthesis (DBT) increases cancer detection rates and significantly reduces the rate of advanced cancers compared to conventional 2D digital ...

Oncology & Cancer

From new treatments to AI: advances in the fight against cancer

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology ...

Oncology & Cancer

Reprogramming cancer cells to attack themselves

A team of health and medical researchers affiliated with a host of institutions across Sweden has tested the possibility of reprogramming cancer cells into cDC1 cells as a means for destroying the protective shield around ...

Oncology & Cancer

Adolescent glioma subtype responds to CDK4/6 inhibitor

CDK4/6 inhibitors, which are already FDA approved for the treatment of other forms of cancer, show early signs of promise in the treatment of a subtype of pediatric high-grade glioma, according to new research from Dana-Farber ...

Oncology & Cancer

The value of knowing the whole person in geriatric oncology

Two recent scientific papers about optimal treatment of older patients with cancer not only improve clinical care but also demonstrate Wilmot Cancer Institute's international leadership in this growing field.

Oncology & Cancer

Interleukin-6 may boost prediction of obesity-related cancers

In patients with newly diagnosed type 2 diabetes, baseline interleukin-6 (IL-6) levels may enhance prediction of new-onset obesity-related cancers, according to a study scheduled to be presented at the annual meeting of the ...